OmniAb, Inc.
General ticker "OABI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $238.8M (TTM average)
OmniAb, Inc. does not follow the US Stock Market performance with the rate: -2.5%.
Estimated limits based on current volatility of 3.4%: low 1.97$, high 2.11$
Factors to consider:
- Total employees count: 7 as of 2021
- Current price 12.4% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.47$, 5.56$]
- 2025-12-31 to 2026-12-31 estimated range: [2.09$, 4.81$]
Financial Metrics affecting the OABI estimates:
- Positive: with PPE of -5.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -10.95 <= 0.33
- Positive: Investing cash flow per share per price, % of 10.46 > -0.66
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 88.35 > 63.39
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term OABI quotes
Long-term OABI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $59.08MM | $34.16MM | $26.39MM |
| Operating Expenses | $85.72MM | $103.58MM | $100.89MM |
| Operating Income | $-26.65MM | $-69.42MM | $-74.50MM |
| Non-Operating Income | $0.59MM | $5.06MM | $3.09MM |
| R&D Expense | $48.36MM | $56.52MM | $55.11MM |
| Income(Loss) | $-26.06MM | $-64.36MM | $-71.41MM |
| Taxes | $-3.73MM | $-13.74MM | $-9.38MM |
| Profit(Loss)* | $-22.33MM | $-50.62MM | $-62.03MM |
| Stockholders Equity | $341.37MM | $314.58MM | $287.62MM |
| Assets | $421.21MM | $375.23MM | $325.56MM |
| Operating Cash Flow | $-3.59MM | $2.35MM | $-39.66MM |
| Capital expenditure | $17.17MM | $1.64MM | $1.88MM |
| Investing Cash Flow | $-73.31MM | $-18.38MM | $37.88MM |
| Financing Cash Flow | $110.74MM | $-0.89MM | $13.02MM |
| Earnings Per Share** | $-0.26 | $-0.51 | $-0.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.